A detailed history of New York State Common Retirement Fund transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,868 shares of ABUS stock, worth $69,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,868
Previous 44,968 51.37%
Holding current value
$69,540
Previous $139,000 39.57%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.12 - $4.56 $72,072 - $105,335
-23,100 Reduced 51.37%
21,868 $84,000
Q2 2024

Jul 31, 2024

BUY
$2.52 - $3.63 $1,562 - $2,250
620 Added 1.4%
44,968 $139,000
Q1 2024

May 07, 2024

SELL
$2.26 - $2.92 $1,487 - $1,921
-658 Reduced 1.46%
44,348 $114,000
Q4 2023

Feb 01, 2024

SELL
$1.69 - $2.54 $405 - $609
-240 Reduced 0.53%
45,006 $113,000
Q3 2023

Nov 07, 2023

BUY
$1.9 - $2.27 $898 - $1,073
473 Added 1.06%
45,246 $92,000
Q2 2023

Aug 07, 2023

SELL
$2.24 - $3.06 $268 - $367
-120 Reduced 0.27%
44,773 $103,000
Q1 2023

May 02, 2023

SELL
$2.23 - $3.1 $68,043 - $94,590
-30,513 Reduced 40.46%
44,893 $136,000
Q4 2022

Jan 30, 2023

SELL
$1.91 - $2.85 $133 - $199
-70 Reduced 0.09%
75,406 $176,000
Q3 2022

Nov 08, 2022

BUY
$1.88 - $2.88 $646 - $990
344 Added 0.46%
75,476 $144,000
Q2 2022

Aug 04, 2022

BUY
$1.98 - $3.17 $82,991 - $132,870
41,915 Added 126.19%
75,132 $204,000
Q1 2022

May 05, 2022

BUY
$2.42 - $3.98 $99 - $163
41 Added 0.12%
33,217 $99,000
Q4 2021

Feb 02, 2022

SELL
$3.11 - $4.61 $454 - $673
-146 Reduced 0.44%
33,176 $129,000
Q3 2021

Nov 02, 2021

SELL
$2.65 - $4.62 $88,981 - $155,130
-33,578 Reduced 50.19%
33,322 $143,000
Q2 2021

Aug 02, 2021

BUY
$2.5 - $3.51 $167,250 - $234,819
66,900 New
66,900 $203,000
Q2 2019

Aug 09, 2019

SELL
$1.46 - $4.44 $35,770 - $108,780
-24,500 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$5.0 - $7.35 $122,500 - $180,075
24,500 New
24,500 $179,000

Others Institutions Holding ABUS

About Arbutus Biopharma Corp


  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $477M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.